Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

3.020

-0.030 (-0.98%)

At close: Aug 14, 2026, 4:00 PM EDT

3.040

+0.020 (0.66%)

After-hours: Aug 14, 2026, 7:42 PM EDT

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	239	509	406	108	125	256
Market Cap Growth	-70.33%	25.25%	277.18%	-14.15%	-50.96%	-14.02%
Enterprise Value	175	448	377	85	117	226
Last Close Price	3.02	6.36	5.30	1.43	1.68	3.74
PE Ratio	15.88	29.26	47.50	-	-	-
Forward PE	32.83	27.81	50.28	160.00	160.00	160.00
PS Ratio	1.86	3.93	4.08	1.29	1.74	3.79
PB Ratio	2.89	6.65	8.81	3.78	4.37	8.06
P/TBV Ratio	3.10	7.18	8.88	3.85	4.48	8.29
P/FCF Ratio	42.20	38.50	33.99	15.45	-	-
P/OCF Ratio	40.25	37.67	33.54	15.13	-	-
EV/Sales Ratio	1.36	3.46	3.78	1.01	1.62	3.35
EV/EBITDA Ratio	18.27	29.68	44.12	-	-	-
EV/EBIT Ratio	20.34	31.31	48.76	-	-	-
EV/FCF Ratio	30.88	33.87	31.54	12.17	-	-
Debt / Equity Ratio	0.03	0.04	0.06	0.12	0.15	0.15
Debt / EBITDA Ratio	0.21	0.17	0.27	-	-	-
Debt / FCF Ratio	0.41	0.21	0.22	0.47	-	-
Net Debt / Equity Ratio	-0.78	-0.81	-0.91	-0.84	-0.56	-0.73
Net Debt / EBITDA Ratio	-6.70	-4.10	-4.90	5.23	0.91	0.90
Net Debt / FCF Ratio	-11.32	-4.68	-3.50	-3.43	1.04	0.95
Asset Turnover	1.30	1.48	1.62	1.53	1.29	1.40
Inventory Turnover	2.63	3.12	3.21	2.25	2.07	2.05
Quick Ratio	5.00	3.73	2.91	1.57	1.61	1.89
Current Ratio	6.50	4.86	3.57	2.40	2.61	2.78
Return on Equity (ROE)	21.80%	28.35%	22.94%	-17.29%	-54.77%	-112.68%
Return on Assets (ROA)	5.44%	10.23%	7.84%	-6.42%	-20.81%	-35.18%
Return on Invested Capital (ROIC)	44.00%	144.16%	169.60%	-65.11%	-176.99%	-542.87%
Return on Capital Employed (ROCE)	9.40%	16.50%	15.40%	-16.30%	-51.50%	-67.30%
Earnings Yield	6.68%	3.42%	2.10%	-4.59%	-13.19%	-10.61%
FCF Yield	2.37%	2.60%	2.94%	6.47%	-12.31%	-9.61%
Buyback Yield / Dilution	-2.25%	-9.36%	-4.19%	-7.54%	-3.79%	-10.02%

SEC Filings: 10-K · 10-Q